LEXINGTON, Mass.--(BUSINESS WIRE)--Synta Pharmaceuticals Corp. (NASDAQ: SNTA), a biopharmaceutical company focused on discovering, developing, and commercializing small molecule drugs to treat severe medical conditions, today announced that the Company will be presenting at the Lazard Capital Markets 6th Annual Healthcare Conference on Wednesday, November 18 at 10:00 a.m. (ET) at the St. Regis New York.
